These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


124 related items for PubMed ID: 8722494

  • 1. Effects of 5-lipoxygenase inhibitors on interleukin production by human synovial tissues in organ culture: comparison with interleukin-1-synthesis inhibitors.
    Rainsford KD, Ying C, Smith F.
    J Pharm Pharmacol; 1996 Jan; 48(1):46-52. PubMed ID: 8722494
    [Abstract] [Full Text] [Related]

  • 2. Selective effects of some 5-lipoxygenase inhibitors on synovial interleukin-1 (IL-1) production compared with IL-1 synthesis inhibitors.
    Rainsford KD, Ying C, Smith F.
    Agents Actions; 1993 Jan; 39 Spec No():C186-8. PubMed ID: 8273563
    [Abstract] [Full Text] [Related]

  • 3. Synthesis of interleukin 1beta, tumor necrosis factor-alpha, and interstitial collagenase (MMP-1) is eicosanoid dependent in human osteoarthritis synovial membrane explants: interactions with antiinflammatory cytokines.
    He W, Pelletier JP, Martel-Pelletier J, Laufer S, Di Battista JA.
    J Rheumatol; 2002 Mar; 29(3):546-53. PubMed ID: 11908571
    [Abstract] [Full Text] [Related]

  • 4. Absence of modulation of monokine production via endogenous cyclooxygenase or 5-lipoxygenase metabolites: MK-886 (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2- dimethylpropanoic acid), indomethacin, or arachidonate fail to alter immunoreactive interleukin-1 beta, or TNF-alpha production by human monocytes in vitro.
    Hoffman T, Lee YL, Lizzio EF, Tripathi AK, Jessop JJ, Taplits M, Abrahamsen TG, Carter CS, Puri J.
    Clin Immunol Immunopathol; 1991 Mar; 58(3):399-408. PubMed ID: 1900463
    [Abstract] [Full Text] [Related]

  • 5. Effects of meloxicam, compared with other NSAIDs, on cartilage proteoglycan metabolism, synovial prostaglandin E2, and production of interleukins 1, 6 and 8, in human and porcine explants in organ culture.
    Rainsford KD, Ying C, Smith FC.
    J Pharm Pharmacol; 1997 Oct; 49(10):991-8. PubMed ID: 9364409
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vivo effects of tepoxalin, an inhibitor of cyclooxygenase and lipoxygenase, on prostanoid and leukotriene production in dogs with chronic osteoarthritis.
    Agnello KA, Reynolds LR, Budsberg SC.
    Am J Vet Res; 2005 Jun; 66(6):966-72. PubMed ID: 16008217
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of antiinflammatory drugs on the release from porcine synovial tissue in vitro of interleukin 1 like cartilage degrading activity.
    Rainsford KD.
    Agents Actions; 1987 Aug; 21(3-4):337-40. PubMed ID: 3500595
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of protein kinase C inhibitors on chemokine production in human synovial fibroblasts.
    Jordan NJ, Watson ML, Yoshimura T, Westwick J.
    Br J Pharmacol; 1996 Mar; 117(6):1245-53. PubMed ID: 8882622
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
    Argentieri DC, Ritchie DM, Ferro MP, Kirchner T, Wachter MP, Anderson DW, Rosenthale ME, Capetola RJ.
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
    [Abstract] [Full Text] [Related]

  • 20. A new class of leukotriene biosynthesis inhibitor: the development of MK-0591.
    Prasit P, Belley M, Blouin M, Brideau C, Chan C, Charleson S, Evans JF, Frenette R, Gauthier JY, Guay J.
    J Lipid Mediat; 1993 Dec; 6(1-3):239-44. PubMed ID: 8357985
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.